[HTML][HTML] Phytoconstituents Profiling of Indigenous Herbal Drugs and Its in vitro Microbial, in Silico Biological Examination against Severe Acute Respiratory Syndrome …

THMA Shareef, MMD Masood… - World Journal of …, 2024 - journals.lww.com
Background: Habb-E-Shifa, Hamdard Sualin, and Hamdard Joshanda traditional herbal
medicines may promote host resistance against infection by bacteria, viruses, and fungi …

[HTML][HTML] Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies

FJ Candel, M Salavert, DL Mingot… - Revista Española de …, 2023 - ncbi.nlm.nih.gov
Recipients of solid organ transplants (SOT) are at higher risk of infection by SARS-CoV-2
virus especially due to chronic immunosuppression therapy and frequent multiple comorbid …

[HTML][HTML] Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern …

E Schiaroli, GV De Socio, A Gidari… - … of Hematology and …, 2022 - ncbi.nlm.nih.gov
Methods In this retrospective observational study, the clinical outcome before and 30 days
after infusion, the baseline neutralizing activity of sera against their viral isolate, and the …

Why Should Vaccines against Respiratory Diseases Go Mucosal? B Cell Epitope-Based Vaccines against SARS-CoV-2

J Tobias, P Steinberger, J Wilkinson, G Klais, M Kundi… - 2024 - preprints.org
Immunity against respiratory pathogens is often short-term, and consequently there is an
unmet need for effective prevention of such infections. One such infectious disease is COVID …

Potential benefit of early treatment with sotrovimab in patients with high risk for severe COVID-19 carrying BA. 2 Infection

M Degli Antoni, C Giagulli, S Messali, S Amadasi… - 2022 - preprints.org
Abstract Coronavirus disease 19 (COVID-19) continues to spread worldwide as a severe
pandemic. The Omicron BA. 2 became the predominant variant and the protagonist of the …

AI-Designed, Mutation-Resistant Broad Neutralizing Antibodies Against Multiple SARS-CoV-2 Strains

Y Kang, Y Jiao, K Jin, L Pan - bioRxiv, 2023 - biorxiv.org
In this study, we generated a Digital Twin for SARS-CoV-2 by integrating data and meta-data
with multiple data types and processing strategies, including machine learning, natural …

Anticorps monoclonaux et immunothérapie: théorie et applications

A Adam - 2024 - papyrus.bib.umontreal.ca
Ce document est une mise à jour d'un précédent publié sur le site Papyrus de l'Université de
Montréal en 2023. Il tient compte des cibles thérapeutiques nouvelles ainsi que des …

Monoclonal antibodies and immunotherapy: theory and applications

A Adam - 2024 - papyrus.bib.umontreal.ca
This document is an update of a previous one published on the Papyrus site of the
University of Montreal in 2023. It takes into account new therapeutic targets as well as …

[PDF][PDF] THE EMERGENCE & EPIDEMIC CHARACTERISTICS OF THE SARS‐COV‐2 OMICRON VARIANT

K Ghule, MR Ahmad, A Gunale, M Gore - 2022 - researchgate.net
Recently, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron
variant (B. 1.1. 529) was first identified in Botswana in November 2021. It was first reported …

Impacts of the Omicron Variant on the Effectiveness of Direct-Acting Antivirals: Replication-Inhibiting Small Molecules and Antibody-Based Therapeutics

J Cheng - … Journal of Experimental Microbiology and Immunology, 2022 - ojs.library.ubc.ca
Since the beginning of the COVID-19 pandemic, researchers have made great progress with
the development of direct-acting antiviral therapies, which are divided into two categories …